A drug candidate for a rare polyalanine disease targeting the protein quality control
Saved in:
Main Authors: | Sharon Pochtar (Author), Avraham Ashkenazi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FOXE1 polyalanine tract length screening by MLPA in idiopathic premature ovarian failure
by: Qin Chun-rong, et al.
Published: (2011) -
Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences
by: Haque Sayedul, et al.
Published: (2007) -
MRX87 family with <it>Aristaless X </it>dup24bp mutation and implication for polyAlanine expansions
by: D'Urso Michele, et al.
Published: (2007) -
New insight into the development of synpolydactyly caused by expansion of HOXD13 polyalanine based on weighted gene co-expression network analysis
by: Xiumin Chen, et al.
Published: (2024) -
Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer
by: Ryosuke Fukuda, et al.
Published: (2018)